ARTICLE | Clinical News
Deoxycholic acid regulatory update
February 16, 2015 8:00 AM UTC
Kythera submitted a regulatory application to Australia’s Therapeutic Goods Administration ( TGA) for ATX-101 to reduce submental (under chin) fat. An NDA for the synthetic sodium deoxycholate is und...